HEIDELBERG UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1386-01-01
- Employees
- -
- Market Cap
- -
EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
- Conditions
- Interventions
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2009-10-06
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 50
- Registration Number
- NCT00982605
- Locations
- 🇩🇪
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care, Heidelberg, Germany
TnThs Predicting Evolving Non-STEMI
Completed
- Conditions
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 115
- Registration Number
- NCT00953251
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
TnThs for Identification Myocardial Infarction
Completed
- Conditions
- First Posted Date
- 2009-07-31
- Last Posted Date
- 2009-07-31
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 94
- Registration Number
- NCT00950469
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma
Phase 2
- Conditions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2009-07-27
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 20
- Registration Number
- NCT00946374
- Locations
- 🇩🇪
University Hospital, Heidelberg, Germany
The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)
- Conditions
- First Posted Date
- 2009-07-09
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 120
- Registration Number
- NCT00935324
- Locations
- 🇩🇪
University of Heidelberg, Heidelberg, Germany
International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-26
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 54
- Registration Number
- NCT00928915
- Locations
- 🇩🇪
Heidelberg University Clinic, Heidelberg, Germany
Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2009-06-25
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 185
- Registration Number
- NCT00927797
Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 40
- Registration Number
- NCT00918489
- Locations
- 🇩🇪
Comprehensive Cancer Center North, University Hospital Kiel, Kiel, Germany
🇩🇪Department of Hematology, Oncology, Rheumatology and Immunology, University Hospital Tübingen, Tübingen, Baden-Württemberg, Germany
🇩🇪Center for Soft Tissue Sarcoma, University Hospital Tübingen, Tübingen, Germany
Efficacy of Methylene Blue for Malaria Treatment in Adults of Burkina Faso: Proof of Principle Study in Semi-Immune Adults of Burkina Faso in the Frame of the A8 Project of the SFB 544
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2009-06-10
- Lead Sponsor
- Heidelberg University
- Registration Number
- NCT00917202
- Locations
- 🇧🇫
Nouna Health District, Nouna, Burkina Faso
Paclitaxel/Carboplatin With or Without Cetuximab in CUP
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2009-05-14
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 150
- Registration Number
- NCT00894569
- Locations
- 🇩🇪
University Hospital Heidelberg, Med. Dep. v, Heidelberg, Germany
© Copyright 2024. All Rights Reserved by MedPath